Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Blood Sugar; High clinical trials

1 of 6 indexed Blood Sugar; High trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Blood Sugar; High: 6 US clinical trials tracked, 1 recruiting.

Blood Sugar; High is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Salk Institute for Biological Studies, running 1 of these trials.

Enrollment posture brief

Registry condition blood-sugar-high

OPEN 1 | RECR 17% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Blood Sugar; High (this)17%
Open-enrollment share among volume-matched conditions near Blood Sugar; High

Blood Sugar; High lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Blood Sugar; High on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Blood Sugar; High is recruiting below its size-band peers.

    1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Blood Sugar; High research.

    Salk Institute for Biological Studies accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Blood Sugar; High trials plan to enrol fewer than 100 people.

    Median target enrolment is 24 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.

  4. Blood Sugar; High research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Blood Sugar; High records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Control: Water Other
1 trials
Control: Tea Other
1 trials
Brewed kombucha tea Dietary supplement
1 trials
Commercial kombucha tea Dietary supplement
1 trials
Resistant Starch Type 4 Other
1 trials
GPC partially digestible maltodextrin Other
1 trials
Isomaltodextrin High Dose Other
1 trials
Isomaltodextrin Low Dose Other
1 trials

US sites by state

Facility locations filed on Blood Sugar; High trials. A trial with sites in several states counts in each.

California 2 trials
Washington 1 trials
Missouri 1 trials
Indiana 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Blood Sugar; High page

6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Sugar; High condition card totals 6 registered trials; most-linked intervention Control: Water; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.